NVCR - NovoCure Limited

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

NovoCure Limited

Full Time Employees782

Key Executives

NameTitlePayExercisedYear Born
Mr. William F. DoyleExec. Chairman1.66MN/A1962
Mr. Asaf DanzigerPres, CEO & Director1.69M58.3M1966
Mr. Wilhelmus C. M. GroenhuysenChief Financial Officer1.02M34.24M1958
Mr. Michael AmbrogiChief Operating Officer660.8k19.86M1963
Mr. Pritesh ShahChief Commercial Officer725.6k6.93M1978
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Corporate Governance

NovoCure Limited’s ISS Governance QualityScore as of December 5, 2019 is 4. The pillar scores are Audit: 1; Board: 4; Shareholder Rights: 4; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.